January 18, 2023
Via: Biopharm InternationalAbbVie and US-based Anima Biotech (Anima) have formed a collaboration to discover and develop messenger RNA (mRNA) biology modulators for three targets across oncology and immunology. In the collaboration, Anima will use its mRNA Lightning technology platform to discover novel […]
January 11, 2023
Via: PMLiVEThe partners will use Anima’s mRNA Lightning platform to discover novel mRNA biology modulators for the collaboration targets, with AbbVie gaining exclusive rights to licence, further develop and commercialise the resulting programmes. In exchange, an upfront payment of $42m will […]
July 11, 2024
July 11, 2024
July 19, 2024
Copyright © 2024. All rights reserved
